SLAMF7 (CD319) enhances cytotoxic T-cell differentiation and sensitizes CD8+ T cells to immune checkpoint blockade
Tumors frequently evade immune destruction by impairing cytotoxic CD8+ T-cell responses, highlighting the need for strategies that restore T-cell functionality. Here, we identify SLAMF7 (CD319) as a key enhancer of human CD8+ T-cell responses against tumors. SLAMF7 expression is induced by pro-infla...
Saved in:
| Main Authors: | Jan-Erik Sander, Irina Han, Lisette Fickenscher, Jörg-Peter Schmidt, Hartmut Kroll, Tereza Vosikova, Martin Durisin, Holger Lingel, Monika C. Brunner-Weinzierl |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1654374/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: A splice donor variant in SLAMF1 is associated with canine atopic dermatitis
by: Frontiers Production Office
Published: (2025-08-01) -
SLAMF8 and NINJ2 promote neuroinflammation and oxidative stress through TLR4 NF kappa B pathway in Alzheimer’s disease
by: Shuo Liu, et al.
Published: (2025-05-01) -
Discordant CAR-T cell signaling: implications of divergence from physiological T cell activation
by: Pablo Gonzalez-Garcia, et al.
Published: (2025-07-01) -
One-Year Outcomes After Belatacept Conversion in Adolescent Kidney Transplant Recipients
by: Charlotte Duneton, et al.
Published: (2025-06-01) -
Percentages of CD4+CD161+ and CD4−CD8−CD161+ T Cells in the Synovial Fluid Are Correlated with Disease Activity in Rheumatoid Arthritis
by: Jinlin Miao, et al.
Published: (2015-01-01)